Betulinic acid-azaprostanoid hybrids: Synthesis and pharmacological evaluation as anti-inflammatory agents Научная публикация
Журнал |
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
|
||||
---|---|---|---|---|---|
Вых. Данные | Год: 2020, Том: 19, Номер: 3, Страницы: 254-267 Страниц : 14 DOI: 10.2174/1871523018666190426152049 | ||||
Ключевые слова | Analgesic activity; Anti-inflammatory activity; Azaprostanoids; Betulinic acid; Cytotoxicity; Hybrids | ||||
Авторы |
|
||||
Организации |
|
Реферат:
Background: Prevention and treatment of chronic inflammatory diseases re-quire effective and low-toxic medicines. Molecular hybridization is an effective strategy to enhance the biological activity of new compounds. Triterpenoid scaffolds are in the focus of attention owing to their anti-inflammatory, antiviral, antiproliferative, and immunomod-ulatory activities. Heteroprostanoids have different pleiotropic effects in acute and chronic inflammatory processes. Objective: The study aimed to develop structurally new and low toxic anti-inflammatory agents via hybridization of betulinic acid with azaprostanoic acids. Methods: A series of betulinic acid-azaprostanoid hybrids was synthesized. The synthetic pathway included the transformation of betulin via Jones' oxidation into betulonic acid, re-ductive amination of the latter and coupling obtained by 3β-amino-3-deoxybetulinic acid with the 7-or 13-azaprostanoic acids and their homo analogues. The hybrids 1-9 were in-vestigated in vivo on histamine-, formalin-and concanavalin A-induced mouse paw edema models and two models of pain-the acetic acid-induced abdominal writhing and the hot-plate test. The hybrids were in vitro evaluated for cytotoxic activity on cancer (MCF7, U-87 MG) and non-cancer humane cell lines. Results: In the immunogenic inflammation model, the substances showed a pronounced anti-inflammatory effect, which was comparable to that of indomethacin. In the models of the exudative inflammation, none of the compounds displayed a statistically significant ef-fect. The hybrids produced weak or moderate analgesic effects. All the agents revealed low cytotoxicity on human immortalized fibroblasts and cancer cell lines compared with 3β-amino-3-deoxybetulinic acid and doxorubicin. Conclusion: The results indicate that the principal anti-inflammatory effect of hybrids is substantially provided with the triterpenoid scaffold and in some cases with the azapros-tanoid scaffold, but the latter makes a significant contribution to reducing the toxicity of hybrids. Hybrid 1 is of interest as a potent low toxic agent against immune-mediated in-flammation. © 2020 Bentham Science Publishers.
Библиографическая ссылка:
Khlebnicova T.S.
, Piven Y.A.
, Lakhvich F.A.
, Sorokina I.V.
, Frolova T.S.
, Baev D.S.
, Tolstikova T.G.
Betulinic acid-azaprostanoid hybrids: Synthesis and pharmacological evaluation as anti-inflammatory agents
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry. 2020. V.19. N3. P.254-267. DOI: 10.2174/1871523018666190426152049 Scopus РИНЦ
Betulinic acid-azaprostanoid hybrids: Synthesis and pharmacological evaluation as anti-inflammatory agents
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry. 2020. V.19. N3. P.254-267. DOI: 10.2174/1871523018666190426152049 Scopus РИНЦ
Файлы:
Полный текст от издателя
Даты:
Опубликована в печати: | 3 сент. 2020 г. |
Идентификаторы:
Scopus | 2-s2.0-85090272152 |
РИНЦ | 45379824 |
OpenAlex | W2941717408 |